期刊文献+

基于CRISPR-Cas9的痘苗病毒高效重组体系的建立 被引量:1

CRISPR-Cas9 system for construction of highly efficient recombinant vaccinia virus
原文传递
导出
摘要 目的利用规律成簇间隔短回文重复序列(clustered regularly interspaced short palindromic repeats,CRISPR)-CRISPR相关蛋白9(CRISPR associated protein 9,Cas9)技术对痘苗病毒(vaccinia virus, VACV)胸腺激酶(thymidine kinase,TK)区进行定向重组,建立高效的痘苗病毒靶基因插入重组技术。方法设计合成靶向TK区的引导RNA(guide RNA, gRNA)对应的2条互补寡核苷酸,磷酸化修饰后变性退火,克隆到去除核定位信号的PX458载体上,同时改造原有TK区重组质粒。将gRNA及Cas9共表达质粒转染293T细胞,介导VACV与TK区重组质粒进行同源重组,然后通过蓝白斑的出现率评估病毒重组率。结果本研究中设计并合成的gRNA序列介导的重组效率大于1%,高于经典的同源重组方法10倍以上。结论本研究利用CRISPR/Cas9技术建立了高效痘苗病毒TK区重组体系,为新发突发传染病的疫苗或多价研究以及肿瘤治疗等提供临床前研究技术支持。 Objective Using clustered regularly interspaced short palindromic repeats(CRISPR)-CRISPR associated protein 9(Cas9)technology to edit Vaccinia virus(VACV)thymidine kinase(TK)Region for targeted recombination to establish an efficient vaccinia virus insertion recombination technology.Methods We designed and synthesized guide RNAs(gRNA)targeting the TK region and then cloned individual gRNA into the PX458 vector that removes nuclear localization signals,and modified the original TK region recombinant plasmid.The gRNA and Cas9 co-expression plasmids were transfected into 293T cells separately to mediate the homologous recombination of vaccinia virus(VACV)and TK region recombination plasmid,and then the rate of viral recombination was evaluated by the appearance of blue and white spots.Results The recombination efficiency mediated by the gRNA sequence designed and synthesized in this study is more than 1%,which is more than 10 times higher than the classical homologous recombination method.Conclusions This study used CRISPR/Cas9 technology to establish a highly efficient recombinant vaccinia virus system,which provides technical support for pre-clinical research in vaccines or multivalent research of emerging infectious diseases,as well as tumor treatment.
作者 吴雅彬 赵莉 任皎 袁航 张鹏 叶飞 田厚文 王文玲 谭文杰 Wu Yabin;Zhao Li;Ren Jiao;Yuan Hang;Zhang Peng;Ye Fei;Tian Houwen;Wang Wenling;Tan Wenjie(National Institute for Viral Disease Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing 102006,China)
出处 《中华实验和临床病毒学杂志》 CAS CSCD 2021年第2期199-204,共6页 Chinese Journal of Experimental and Clinical Virology
基金 国家科技重大专项(2018ZX10731301-002-003)。
关键词 痘苗病毒 CRISPR/Cas9 高效重组系统 Vaccinia virus CRISPR/Cas9 Efficient recombination system
  • 相关文献

参考文献3

二级参考文献42

  • 1Gomez C E, Najera G J, Krupa M, et al, MVA and NYVAC as vaccines against emergent infectious diseases and cancer [J]. Curr Gene Ther, 2011,11(3):189-217.
  • 2Pastoret P P, Vanderplasschen A. Poxviruses as vaccine vec- tors[J]. Comp Immunol Microbiol Infect Dis, 2003,26(5-6):343- 355.
  • 3Sutter G, Staib C. Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen de- livery[J]. Curt Drug Targets Infect Disord, 2003,3(3):263-271.
  • 4Tartaglia J, Perkus M E, Taylor J, et al. NYVAC: a highly at- tenuated strain of vaccinia virus[J]. Virology, 1992,188(1):217- 232.
  • 5阮力,朱既明,娄元梅,等.复制缺陷型天坛株痘苗病毒[P].中国专利,200610056800.0,2008-06-11.
  • 6Najera J L, Gomez C E, Domingo-Gil E, et al. Cellular and biochemical differences between two attenuated poxvirus vac- cine candidates(MVA and NYVAC) and role of the C7L gene [J]. J Virol, 2006,80(12):6033-6047.
  • 7Backes S, Sperling K M, Zwilling J, et al. Viral host-range factor C7 or K1 is essential for modified vaccinia virus Anka- ra late gene expression in human and murine cells, irrespec- tive of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2alpha [J]. J Gen Virol, 2010,91(Pt 2):470-482.
  • 8Willis K L, Patel S, Xiang Y, et al., The effect of the vaccin- ia K1 protein on the PKR-eIF2alpha pathway in RK13 and HeLa cells[J]. Virology, 2009,394(1):73-81.
  • 9Willis K L, Langland J O, Shisler J L. Viral double-stranded RNAs from vaccinia virus early or intermediate gene tran- scripts possess PKR activating function, resulting in NF-kap- paB activation, when the K1 protein is absent or mutated[J]. J Biol Chem, 2011,286(10):7765-7778.
  • 10Meng X, Jiang C, Arsenio J, et al. Vaccinia virus KIL and CTL inhibit antiviral activities induced by type I interferons [J]. J Virol, 2009,83(20):10627-10636.

共引文献8

同被引文献1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部